Real‐Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy‐Gastric Juice Analysis Approach
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.18378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Riccardo Vasapolli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine II, University Hospital LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents, Clarithromycin. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsches Zentrum für Infektionsforschung.
Abstract (Originalsprache)
Background
Helicobacter pylori antibiotic resistance is the most relevant cause of treatment failure. Antibiotic susceptibility testing (AST) allows for selecting the appropriate eradication regimen.
Aims
To assess the diagnostic accuracy of gastric aspirate‐based genotypic AST (G‐AST) for detecting clarithromycin and levofloxacin resistance compared with conventional phenotypic AST (P‐AST).
Methods
We recruited 461 consecutive patients scheduled for endoscopy. H. pylori was detected intraprocedurally using Endofaster, a novel method combining endoscopy with gastric juice analysis. For H. pylori ‐positive patients, we collected gastric aspirates and biopsies. G‐AST was performed using DNA extracted from aspirates, with Sanger sequencing to detect polymorphisms in the 23S rRNA and gyrA genes associated, respectively, with resistance to macrolides and fluoroquinolones. P‐AST was performed on H. pylori isolated from biopsies using ETEST.
Results
One hundred and seventy‐eight (40.4%) patients tested positive for H. pylori during endoscopy. Paired gastric biopsies and aspirates were available from 152 H. pylori ‐positive patients. By P‐AST, resistance rates were 15.1% (23/152) for clarithromycin and 18.4% (28/152) for levofloxacin. G‐AST showed a high level of agreement with P‐AST for clarithromycin (kappa 0.86) and levofloxacin (kappa 0.81) resistance and diagnostic accuracy of 97% and 95%, respectively.
Conclusions
The novel method combining endoscopy with immediate intraprocedural gastric juice analysis for the detection of H. pylori , followed by AST in case of a positive finding, is valid and practical for tailoring eradication regimens for H. pylori infection. Genotypic AST from gastric aspirates is highly accurate for detecting clarithromycin and levofloxacin resistances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine II, University Hospital LMU Munich, Munich, Germany.
- DZIF Deutsches Zentrum für Infektionsforschung, Partner Site Munich, Munich, Germany.
- Max von Pettenkofer Institute, Faculty of Medicine, Ludwig Maximilians University of Munich, Munich, Germany.
- National Reference Center for Helicobacter Pylori, Munich, Germany.
ORCID-Profile: Riccardo Vasapolli, Peter Malfertheiner
Förderung
- Deutsches Zentrum für Infektionsforschung
Zitieren
APA
Vasapolli, R., Ailloud, F., Spießberger, B., Malfertheiner, P., Suerbaum, S., & Schulz, C. (2025). Real‐Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy‐Gastric Juice Analysis Approach. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18378
Vancouver
Vasapolli R, Ailloud F, Spießberger B, Malfertheiner P, Suerbaum S, Schulz C. Real‐Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy‐Gastric Juice Analysis Approach. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18378
BibTeX
@article{Vasapolli2025,
author = {Vasapolli, Riccardo and Ailloud, Florent and Spießberger, Beate and Malfertheiner, Peter and Suerbaum, Sebastian and Schulz, Christian},
title = {Real‐Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy‐Gastric Juice Analysis Approach},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.18378}
}
EUVIMED